(Q46826393)

25 December 2017

title

Plasma succinylacetone is persistently raised after liver transplantation in tyrosinaemia type 1. (English)

1 reference

25 December 2017

main subject

nitisinone

1 reference

ChEBI release 2020-05-28

1 reference

ChEBI release 2020-05-28

ChEBI ID

87897

liver transplantation

1 reference

1

1 reference

25 December 2017

Philip Newsome

5

1 reference

25 December 2017

author name string

Mary Anne Preece

2

1 reference

25 December 2017

Elisabeth Holme

3

1 reference

25 December 2017

Carla Lloyd

4

1 reference

25 December 2017

Patrick J McKiernan

6

1 reference

25 December 2017

publication date

29 March 2012

1 reference

25 December 2017

Journal of Inherited Metabolic Disease

published in

1 reference

25 December 2017

volume

36

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

15-20

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s10545-012-9482-1

exact match

0 references

cites work

Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Clinical practice. NTBC therapy for tyrosinemia type 1: how much is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Screening for tyrosinaemia type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

21 January 2018

Tyrosinemia: a review

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Renal tubular function in children with tyrosinaemia type I treated with nitisinone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Determination of urinary succinylacetone by capillary gas chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9482-1

Tyrosinemia: the Quebec experience

21 January 2018

1 reference

12 December 2020

Liver transplantation for hereditary tyrosinemia: the Quebec experience

1 reference

12 December 2020

Nephropathy of tyrosinemia and its long-term outlook

1 reference

12 December 2020

A study of the determination of 5-aminolevulinate hydro-lyase (delta-aminolevulinate dehydratase) activity in hemolysates of human erythrocytes

1 reference

12 December 2020

Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement

1 reference

12 December 2020

Fumarylacetoacetase measurement as a mass-screening procedure for hereditary tyrosinemia type I

1 reference

12 December 2020

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents

1 reference

12 December 2020

Indications and outcome of liver transplantation in tyrosinaemia type 1

1 reference

12 December 2020

Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma

1 reference

12 December 2020

The Nephropathy of Type I Tyrosinemia after Liver Transplantation

1 reference

12 December 2020

Urinary organic acids: isolation and quantification for routine metabolic screening

1 reference

12 December 2020

Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation

1 reference

12 December 2020

10.1007/S10545-012-9482-1

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017